PRIOR PRINTER'S NO. 2835
PRINTER'S NO. 3532
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
1698
Session of
2015
INTRODUCED BY HEFFLEY, KINSEY, THOMAS, DRISCOLL, MARSICO,
DiGIROLAMO, TOEPEL, KILLION, HARHAI, TAYLOR, D. PARKER,
TOOHIL, SCHLEGEL CULVER, MASSER, JOZWIAK, HAHN, WARD, KAUFER,
ROZZI, SNYDER, LONGIETTI, HARHART, STAATS, GIBBONS, KLUNK,
O'BRIEN, MURT, BOBACK, GOODMAN, READSHAW, SAYLOR, COHEN,
NESBIT, FABRIZIO, SCHLOSSBERG, MOUL, EVERETT, DONATUCCI,
R. BROWN, PHILLIPS-HILL AND FARRY, FEBRUARY 9, 2016
AS REPORTED FROM COMMITTEE ON HEALTH, HOUSE OF REPRESENTATIVES,
AS AMENDED, JUNE 15, 2016
AN ACT
Providing for coverage requirements by an insurance carrier or
health insurance plan for abuse-deterrent opioid analgesic
drug products.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Short title.
This act shall be known and may be cited as the Abuse-
Deterrent Opioid Analgesic Drug Products Coverage Act.
Section 2. Findings and declarations.
The General Assembly finds and declares as follows:
(1) The abuse of opioids is a serious problem that
affects the health, social and economic welfare of this
Commonwealth.
(2) An estimated 2.1 million people in the United States
suffered from substance use disorders related to prescription
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15